Hypothetical $10,000 invested at their first disclosed trade date. · log scale
Hypothetical backtest based on disclosed trades. Past performance does not predict future results. Not investment advice.
| Ticker | Action | Description | Traded |
|---|---|---|---|
| GAP | Sell | Gap, Inc. | Aug 21, 2025 |
| ORMP | Sell | Oramed Pharmaceuticals Inc. | Jan 14, 2022 |
| TELL | Buy | Tellurian Inc. | Jan 14, 2022 |
| GPS | Buy | Gap, Inc. | Oct 1, 2021 |
| OSW | Sell | OneSpaWorld Holdings Limited | Oct 1, 2021 |
| ORMP | Sell | Oramed Pharmaceuticals Inc. | Oct 1, 2021 |
| TELL | Buy | Tellurian Inc. | Oct 1, 2021 |
| OTHER | Buy | VMCCX | Jun 7, 2021 |
| OTHER | Sell | Capital World Grow and Incom | Jun 3, 2021 |
| BAC | Sell | bank of America Corporation | Apr 23, 2021 |
Andrew Garbarino is a United States Representative from NY affiliated with the Republican Party, serving in the US House of Representatives. Disclosed Capitol tracks 14 disclosed stock trades from Andrew Garbarino, filed under the STOCK Act. The portfolio compounds at 4.1% annualized — 4.4% below the S&P 500 benchmark over the same period, with a 43% win rate on individual trades. The full trade history, holdings, sector allocation, and risk metrics are below.
Andrew Garbarino (R-NY) has disclosed 14 trades under the STOCK Act; portfolio CAGR of 4.1% (-4.4% vs. the S&P 500); top tickers traded: ORMP, TELL, OSW.
Full trade list with transaction dates, disclosure dates, tickers, and amount ranges is in the interactive table below.
Most-traded tickers: ORMP, TELL, OSW. Sector allocation and portfolio weighting appear in the Holdings panel.
Annualized return: 4.1% CAGR, -4.4% alpha vs. the S&P 500. Detailed performance charts are in the Performance panel.
Andrew Garbarino's disclosed stock portfolio is valued at approximately $184 across 1 tracked positions. This reflects only publicly disclosed, exchange-traded securities from STOCK Act filings — it excludes real estate, private assets, cash, and liabilities, so it is a partial floor on Andrew Garbarino's total net worth, not a complete measure of it.